Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Citation: Boominathan, Insights into the treatment of Fibrosis: NR2F2 suppresses the expression of TGFß receptor II (TGFBR2) and extracellular matrix proteins via up regulation of its target gene, 26/October/2014, 10.05 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Significance: This study suggests that NR2F2, by increasing the expression of its target gene, it may decrease the expression of TGFß receptor II (TGFBR2) and extracellular matrix proteins. Thus, pharmacological formulations encompassing “NR2F2 activators“ may be used to treat fibrosis.
Amount: $300
Undisclosed information: An insight into how NR2F2 suppresses the expression of TGFß receptor II (TGFBR2) and extracellular matrix proteins.
Courtesy: When you cite drop us a line at info@genomediscovery.org
Web: http://genomediscovery.org
